Paralel Advisors’s Elevance Health ELV Stock Holding History

Paralel Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.8M	Hold	6,150	–	–	0.07%	84
2025 Q4	$2.16M	Hold	6,150	–	–	0.08%	77
2025 Q3	$1.99M	Buy	6,150 +7	+0.1%	+$2.18K	0.08%	85
2025 Q2	$2.39M	Buy	6,143 +1,300	+27%	+$523K	0.1%	80
2025 Q1	$2.11M	Hold	4,843	–	–	0.09%	77
2024 Q4	$1.79M	Buy	4,843 +440	+10%	+$184K	0.08%	91
2024 Q3	$2.29M	Hold	4,403	–	–	0.1%	67
2024 Q2	$2.39M	Buy	4,403 +243	+6%	+$128K	0.11%	39
2024 Q1	$2.16M	Hold	4,160	–	–	0.1%	65
2023 Q4	$1.96M	Hold	4,160	–	–	0.1%	71
2023 Q3	$1.81M	Buy	4,160 +47	+1%	+$21.3K	0.1%	59
2023 Q2	$1.83M	Buy	4,113 +461	+13%	+$213K	0.1%	67
2023 Q1	$1.68M	Buy	3,652 +96	+3%	+$45.7K	0.09%	58
2022 Q4	$1.82M	Buy	+3,556	New	+$1.81M	0.11%	44

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Paralel Advisors's ELV Position: Q1 2026 in Review

Paralel Advisors held its Elevance Health (ELV) position steady in Q1 2026 at 6,150 shares worth $1.8M. The position accounts for 0.07% of the portfolio, ranked #84.

Paralel Advisors first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.39M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Paralel Advisors held 6,150 shares of Elevance Health worth $1.8M as of Q1 2026.
Paralel Advisors left its Elevance Health share count unchanged in Q1 2026.
Elevance Health made up 0.07% of Paralel Advisors's portfolio in Q1 2026, its #84 holding.
Paralel Advisors first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
Paralel Advisors's Elevance Health position peaked at $2.39M in Q2 2025.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Paralel Advisors's 13F filing for Q1 2026, filed 8 May 2026.